Decline in SESN2 Expression During Aging Shifts Mesenchymal Stem Cell Differentiation from Osteogenic to Adipogenic Lineage
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Sestrin 2 (SESN2) is a member of the sestrin family of stress-induced proteins that negatively regulate agingassociated biological processes. This study aims to investigate the role of SESN2 in regulating the differentiation potential and senescence of mesenchymal stem cells (MSCs) derived from young and elderly donors. Bulk RNA sequencing revealed a common decline in the SESN2 mRNA levels in MSCs from elderly individuals, which was confirmed via reverse transcription-polymerase chain reaction and western blot analyses. SESN2 knockdown in MSCs from young donors resulted in phenotypic changes similar to those in MSCs from elderly donors, including an enhanced expression of senescence and adipogenic markers and diminished expression of osteogenic markers. To confirm the effect of decreased SESN2 expression on osteogenic and adipogenic differentiation, we induced Sesn2 knockdown in mouse bone marrow-derived MSCs. Sesn2 knockdown suppressed the mRNA expression of osteogenic marker genes, alkaline phosphatase activity, and matrix mineralization. Furthermore, Sesn2 knockdown enhanced mRNA expression of the adipogenic marker genes and intracellular lipid accumulation. These results suggest that a decline in SESN2 expression during aging contributes to the shift of MSC differentiation from osteogenic to adipogenic lineage.
Abstract
Sestrin 2 (SESN2) is a member of the sestrin family of stress-induced proteins that negatively regulate agingassociated biological processes. This study aims to investigate the role of SESN2 in regulating the differentiation potential and senescence of mesenchymal stem cells (MSCs) derived from young and elderly donors. Bulk RNA sequencing revealed a common decline in the SESN2 mRNA levels in MSCs from elderly individuals, which was confirmed via reverse transcription-polymerase chain reaction and western blot analyses. SESN2 knockdown in MSCs from young donors resulted in phenotypic changes similar to those in MSCs from elderly donors, including an enhanced expression of senescence and adipogenic markers and diminished expression of osteogenic markers. To confirm the effect of decreased SESN2 expression on osteogenic and adipogenic differentiation, we induced Sesn2 knockdown in mouse bone marrow-derived MSCs. Sesn2 knockdown suppressed the mRNA expression of osteogenic marker genes, alkaline phosphatase activity, and matrix mineralization. Furthermore, Sesn2 knockdown enhanced mRNA expression of the adipogenic marker genes and intracellular lipid accumulation. These results suggest that a decline in SESN2 expression during aging contributes to the shift of MSC differentiation from osteogenic to adipogenic lineage.
참고문헌 (31)
- Lee JH, "Sestrins orchestrate cellular metabolism to attenuate aging", Cell Metab, 18, pp.792~801 (2013)[DOI]
- Lee JH, "Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies", Science, 327, pp.1223~1228 (2010)[DOI]
- Budanov AV, "Stressin’ Sestrins take an aging fight", EMBO Mol Med, 2, pp.388~400 (2010)[DOI]
- Chen Y, "The functions and roles of sestrins in regulating human diseases", Cell Mol Biol Lett, 27, pp.2~ (2022)[DOI]
- Xu D, "Evidence for a role for Sestrin1 in mediating leucine-induced activation of mTORC1 in skeletal muscle", Am J Physiol Endocrinol Metab, 316, pp.E817~28 (2019)[DOI]
- Fang H, "Role of sestrins in metabolic and aging-related diseases", Biogerontology, 25, pp.9~22 (2024)[DOI]
- Guillén C, "mTORC1 overactivation as a key aging factor in the progression to type 2 diabetes mellitus", Front Endocrinol(Lausanne), 9, pp.621~ (2018)[DOI]
- Johnson SC, "mTOR is a key modulator of ageing and age-related disease", Nature, 493, pp.338~345 (2013)[DOI]
- Musina RA, "Comparison of mesenchymal stem cells obtained from different human tissues", Bull Exp Biol Med, 139, pp.504~509 (2005)[DOI]
- Bergman RJ, "Age-related changes in osteogenic stem cells in mice", J Bone Miner Res, 11, pp.568~577 (1996)[DOI]
- Justesen J, "Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis", Biogerontology, 2, pp.165~171 (2001)[DOI]
- Lin Z, "MicroRNA-130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate", Cell Prolif, 52, pp.e12688~ (2019)[DOI]
- Li CJ, "MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation", J Clin Invest, 125, pp.1509~1522 (2015)[DOI]
- Li X, "Dysfunction of metabolic activity of bone marrow mesenchymal stem cells in aged mice", Cell Prolif, 55, pp.e13191~ (2022)[DOI]
- Josephson AM, "Age-related inflammation triggers skeletal stem", progenitor cell dysfunction, 2019, pp.116, 6995~7004
- Ganguly P, "Age-related changes in bone marrow mesenchymal stromal cells : a potential impact on osteoporosis and osteoarthritis development", Cell Transplant, 26, pp.1520~1529 (2017)[DOI]
- Wang YG, "AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis", Cell Signal, 28, pp.1270~1282 (2016)[DOI]
- Ling NXY, "mTORC1directly inhibits AMPK to promote cell proliferation under nutrient stress", Nat Metab, 2, pp.41~49 (2020)[DOI]
- Qadir AS, "miR-124 negatively regulates osteogenic differentiation and in vivo bone formation of mesenchymal stem cells", J Cell Biochem, 116, pp.730~742 (2015)[DOI]
- Lee HL, "Distal-less homeobox 5 inhibits adipogenic differentiation through the down-regulation of peroxisome proliferator-activated receptor γ expression", J Cell Physiol, 228, pp.87~98 (2013)[DOI]
- Khosla S, "Cellular senescence and the skeleton : pathophysiology and therapeutic implications", J Clin Invest, 132, pp.e154888~ (2022)[DOI]
- Stenderup K, "Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells", Bone, 33, pp.919~926 (2003)[DOI]
- Shen T, "Suppression of Sestrins in aging and osteoarthritic cartilage : dysfunction of an important stress defense mechanism", Osteoarthritis Cartilage, 25, pp.287~296 (2017)[DOI]
- Rajan SP, "Serum sestrins : potential predictive molecule in human sarcopenia", Aging Clin Exp Res, 33, pp.1315~1324 (2021)[DOI]
- Rai N, "Exploration of novel antioxidant protein Sestrin in frailty syndrome in elderly", Aging Dis, 9, pp.220~227 (2018)[DOI]
- Hwang CY, "Sestrin2attenuates cellular senescence by inhibiting NADPH oxidase 4 expression", Ann Geriatr Med Res, 24, pp.297~304 (2020)[DOI]
- Kong S, "Allicin regulates Sestrin2ubiquitination to affect macrophage autophagy and senescence, thus inhibiting the growth of hepatoma cells", Tissue Cell, 88, pp.102398~ (2024)[DOI]
- Wang H, "Sestrin2 is increased in calcific aortic disease and inhibits osteoblastic differentiation in valvular interstitial cells via the nuclear factor E2-related factor 2 pathway", J Cardiovasc Pharmacol, 80, pp.609~615 (2022)[DOI]
- Atashi F, "The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation : a review", Stem Cells Dev, 24, pp.1150~1163 (2015)[DOI]
- Martin SK, "Brief report : the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation", Stem Cells, 33, pp.1359~1365 (2015)[DOI]
- Kim EK, "Human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by AMPactivated protein kinase", J Cell Physiol, 227, pp.1680~1687 (2012)[DOI]